Core Points - Sinovac has signed two Product Development Partnership (PDP) projects with the Brazilian Ministry of Health, marking it as the first Chinese vaccine company to win such contracts [1] - The collaboration aims to enhance Brazil's local vaccine production capacity, with plans to supply approximately 60 million doses of varicella and rabies vaccines over the next decade, valued at over $700 million [1] - The signing ceremony was attended by key Brazilian officials, highlighting the importance of this partnership in strengthening public health systems in Brazil [1] Group 1 - Sinovac will collaborate with local partners Tecpar and Eurofarma to establish a vaccine industry platform in Brazil [2] - This partnership not only ensures the accessibility of vaccines in Brazil but also benefits many countries in the Global South [2] - The cooperation signifies a deepening of the long-term collaborative relationship between Sinovac and Brazil, extending beyond vaccines to broader biopharmaceutical strategic cooperation [2]
科兴与巴西卫生部开启十年合作 强化当地疫苗供应链